Venous thromboembolic events in hospitalised medical patients

Thrombosis and Haemostasis

Volumn 102, Issue 3, 2009, Pages 505-510

  Piazza, Gregory ^a   Fanikos, John ^a   Zayaruzny, Maksim ^b   Goldhaber, Samuel Z ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Deep vein thrombosis; Medical patients; Prophylaxis; Pulmonary embolism; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT;

ARTICLE; DEEP VEIN THROMBOSIS; HEART FAILURE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LUNG EMBOLISM; MORTALITY; NEOPLASM; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY FAILURE; RISK FACTOR; VENOUS THROMBOEMBOLISM;

ACUTE DISEASE; ALGORITHMS; HOSPITALIZATION; HOSPITALS; HUMANS; INPATIENTS; MODELS, STATISTICAL; MODELS, THEORETICAL; PROBABILITY; PULMONARY EMBOLISM; RISK; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 70449347222     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-03-0150     Document Type: Article

References (39)

1. MacDougall DA, Feliu AL, Boccuzzi SJ, et al. Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. Am J Health Syst Pharm 2006; 63: S5-15.
2. Kahn SR, Shrier I, Julian JA, et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008; 149: 698-707.
3. Lang IM, Klepetko W. Chronic thromboembolic pulmonary hypertension: an updated review. Curr Opin Cardiol 2008; 23: 555-559.
4. Piazza G, Seddighzadeh A, Goldhaber SZ. Double trouble for 2,609 hospitalised medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent. Chest 2007; 132: 554-561. (Pubitemid 47282388)
5. Spencer FA, Lessard D, Emery C, et al. Venous thromboembolism in the outpatient setting. Arch Intern Med 2007; 167: 1471-1475.
6. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008; 133: 381S-453S. (Pubitemid 351894916)
7. Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol 2006; 25: 101-161.
8. Amin A, Stemkowski S, Lin J, et al. Thromboprophylaxis rates in US medical centers: success or failure? J Thromb Haemost 2007; 5: 1610-1616.
9. Kahn SR, Panju A, Geerts W, et al. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res 2007; 119: 145-155. (Pubitemid 44810862)
10. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008; 371: 387-394.
11. Anderson FA, Jr., Zayaruzny M, Heit JA, et al. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 2007; 82: 777-782. (Pubitemid 350194504)
12. Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756-764.
13. Yu HT, Dylan ML, Lin J, et al. Hospitals' compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm 2007; 64: 69-76. (Pubitemid 46395711)
14. Warlow C, Terry G, Kenmure AC, et al. A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet 1973; 2: 934-936.
15. Sherman DG, Albers GW, Bladin C, et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Lancet 2007; 369: 1347-1355. (Pubitemid 46621092)
16. Khorana AA, Francis CW, Culakova E, et al. Thromboembolism in hospitalised neutropenic cancer patients. J Clin Oncol 2006; 24: 484-490. (Pubitemid 46630468)
17. Harenberg J, Schomaker U, Flosbach CM. Enoxaparin is superior to unfractionated heparin in the prevention of thromboembolic events in medical patients at increased thromboembolic risk. Blood 1999; 94 (Suppl): 399a.
18. Handley AJ. Low-dose heparin after myocardial infarction. Lancet 1972; 2: 623-624.
19. Cohen AT, Turpie AG, Leizorovicz A, et al. Thromboprophylaxis with dalteparin in medical patients: which patients benefit? Vasc Med 2007; 12: 123-127.
20. Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalised patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 2004; 164: 963-968. (Pubitemid 38581515)
21. Alikhan R, Cohen AT, Combe S, et al. Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis 2003; 14: 341-346. (Pubitemid 36688187)
22. Oster G, Tuden RL, Colditz GA. A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery. J Am Med Assoc 1987; 257: 203-208. (Pubitemid 17207832)
23. Ades AE, Claxton K, Sculpher M. Evidence synthesis, parameter correlation and probabilistic sensitivity analysis. Health Econ 2006; 15: 373-381.
24. Doubilet P, Begg CB, Weinstein MC, et al. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making 1985; 5: 157-177.
25. Stein PD, Beemath A, Meyers FA, et al. Incidence of venous thromboembolism in patients hospitalised with cancer. Am J Med 2006; 119: 60-68. (Pubitemid 43117468)
26. Shetty R, Seddighzadeh A, Piazza G, et al. Chronic obstructive pulmonary disease and deep vein thrombosis: a prevalent combination. J Thromb Thrombolysis 2008; 26: 35-40.
27. Kelly J, Rudd A, Lewis R, et al. Venous thromboembolism after acute stroke. Stroke 2001; 32: 262-267.
28. Beemath A, Stein PD, Skaf E, et al. Risk of venous thromboembolism in patients hospitalised with heart failure. Am J Cardiol 2006; 98: 793-795. (Pubitemid 44301013)
29. Seddighzadeh A, Shetty R, Goldhaber SZ. Venous thromboembolism in patients with active cancer. Thromb Haemost 2007; 98: 656-661. (Pubitemid 47412893)
30. Piazza G, Seddighzadeh A, Goldhaber SZ. Heart failure in patients with deep vein thrombosis. Am J Cardiol 2008; 101: 1056-1059.
31. Wein L, Wein S, Haas SJ, et al. Pharmacological venous thromboembolism prophylaxis in hospitalised medical patients: a meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167: 1476-1486. (Pubitemid 47124178)
32. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800.
33. Leizorovicz A, Cohen AT, Turpie AG, et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110: 874-879. (Pubitemid 39096017)
34. Dentali F, Douketis JD, Gianni M, et al. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalised medical patients. Ann Intern Med 2007; 146: 278-288. (Pubitemid 351650614)
35. Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. Br Med J 2006; 332: 325-329.
36. The surgeon general's call to action to prevent deep vein thrombosis and pulmonary embolism. U.S. Department of Health and Human Services. 2008. Available at: www.surgeongeneral.gov/topics/deepvein/calltoaction/call-to- action-on-dvt-2008.pdf. Accessed 11/30/08.
37. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalised patients. N Engl J Med 2005; 352: 969-977. (Pubitemid 40349499)
38. Lecumberri R, Marques M, Diaz-Navarlaz MT, et al. Maintained effectiveness of an electronic alert system to prevent venous thromboembolism among hospitalised patients. Thromb Haemost 2008; 100: 699-704.
39. Piazza G, Rosenbaum E, Pendergast W, et al. Physician alerts to prevent symptomatic venous thromboembolism in hospitalised patients. Circulation 2009; 119: 2196-2201.